D3-treated cells. In contrast, anti-TNF-ot antibodies markedly decreased HIV production in both control and differentiating U937 cells. Vitamin D3 treatment resulted in a higher expression of TNF receptors in differentiating cells than in control HIV-infected cells. These data demonstrate a strong correlation between HIV production and macrophagelike differentiation in chronically infected U937 cells and suggest that endogenous IFN and TNF exert opposite effects in the regulation of virus production in both undifferentiated and vitamin D3-treated cell cultures.
Many experimental and clinical data indicate that macrophages play a crucial role in the pathogenesis of acquired immunodeficiency syndrome (AIDS) (reviewed in reference 39) .
A number of data indicate that monocytes and related cells are infected by human immunodeficiency virus (HIV) type 1 (7, 15, 20) . Infection of these cells has been associated with the fact that certain monocytes express CD4 molecules on their surface (4, 31, 45) . HIV type 1 has been isolated from macrophages of brain (14) , lymph node (19) , and lung (1, 40) tissues and peripheral blood leukocytes (19) of infected individuals. In vitro infection of macrophages has been reported (16) , and monocytotropic HIV variants have been isolated (37) . Infected monocytes and tissue macrophages are relatively resistant to the cytopathic effect of HIV type 1, suggesting that they might serve as reservoirs of the virus and contribute to HIV persistence in vivo. In fact, macrophages can be latently infected with HIV in vivo for long periods until activation signals trigger viral expression subsequently resulting in the onset of clinical AIDS symptoms. The importance and the role of activation signals in the induction of HIV expression have been widely demonstrated during initial attempts to isolate the virus from blood cells of * Corresponding author. patients with AIDS (13, 26) . Accumulation of viral mRNA in infected cells is sensitive to a variety of stimuli; among these, antigens, mitogens, phorbol ester, cellular transcription factors, and transfected genes of other viruses can convert a latent HIV infection into a productive infection. In this context, cytokines produced in response to a variety of stimuli, including viral and bacterial infections, have been considered to play important roles in the clinical progression of AIDS (38) . Some cytokines, such as tumor necrosis factor (TNF), interleukin 1 (IL-1), and colony-stimulating factors, have been shown to enhance HIV expression in different cell systems (reviewed in reference 38), whereas other cytokines, such as interferons (IFNs) have been reported to exhibit some anti-HIV activity in vitro (3, 30, 36) . In particular, it has been found that TNF-a is capable of increasing viral production in activated macrophages, possibly through the action of the NF-KB protein (18) .
The human promonocytic cell line U937 (42) has been used to study some aspects of monocyte/macrophage differentiation under defined in vitro conditions. A few research groups have already reported on the biology of HIV infection in U937 cells (9-11, 27, 33, 35, 36) .
In particular, Folks and coworkers reported that the addition of 13-phorbol-12-myristate acetate (PMA) to a cloned line of chronically infected U937 cells resulted in a marked increase of HIV production (11) ; likewise, TNF-a treatment increased HIV release, which was supposed to be mediated by an increased NF-KB-binding activity, in this cell line (18) . In such studies, the increased HIV production has been observed after short-term treatments with these agents under conditions known to induce some macrophage activation rather than long-term differentiation. The following major questions still needed to be addressed in some Cytokine detection in cell supernatants. The presence of TNF-a, IL-lot, IL-1,, and IL-6 in the cell supernatants was measured by means of enzyme-linked immunosorbent assays (T Cell Sciences Inc., Cambridge, Mass.; Endogen Inc., Boston, Mass.; Cistron Biotechnology, Pine Brook, N.J.; and Quantikine, R and D Systems, Minneapolis, Minn., respectively). The cell supernatants were titrated for IFN activity as described elsewhere (41) . Briefly, the IFN titer was determined by inhibition of Sindbis virus hemagglutinin yield after a single growth cycle.
RNA PCR analysis of TNF-a and IFN-eA. The RNA polymerase chain reaction (PCR) was performed as described elsewhere (23; S. L. Diamond, J. B. Sharefkin, L. V. McIntire, C. W. Dieffenbach, K. Fraiser-Scott, and S. G. Eskin, J. Cell. Physiol., in press) with the following modifications. For the RT reactions, 0.6 jig of total cellular RNA was mixed with 300 ng of each antisense primer for either TNF-ot or IFN-oaA and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in RT buffer and processed as described elsewhere (23) . GAPDH amplification serves as an internal control and is a check for consistent RT reactions. For the cDNA PCR, each RT reaction mixture was split into two parts, one-third for GAPDH and two-thirds for either TNF-at or IFN-a.A. The reaction conditions were as described previously (23) , except the primer concentration was 300 ng for both sense and antisense primers. The PCR was then run for 20 cycles of 90 s at 94°C, 90 s at 50°C, and 60 s at 72°C. After the PCR, the samples were analyzed as described elsewhere (23; Diamond et al., in press). The sequences of the primers used are shown in Table 1 (Fig. 1A) . HIV-infected U937 cells were cloned by the dilution method approximately 80 days after HIV infection. All the tested clones (i.e., 15 of 15) released HIV in the cell medium, as determined by the p24 assay, even though some differences were observed in the amounts of the released virus (data not shown); these data indicated that virtually all the U937 cells were HIV infected.
The HIV-infected U937 cells exhibited in vitro growth curves very similar to those of uninfected cell cultures. We then measured the expression of several membrane markers (i.e., OKM1, TecMG2, TecMG3, LeuMl, LeuM3, OKM14, OKM13, OKM5, HLA-DR, HLA-DQ, HLA-DP, and CD4) in the HIV-infected U937 cells as well as in their uninfected counterparts. HIV-infected U937 cells exhibited a markedly lower expression of CD4, HLA-DR, and HLA-DP antigens than uninfected U937 cells did (Fig. 1B) .
Modulation of membrane antigens in HIV-infected cells after hydroxyvitD3 treatment. HydroxyvitD3 has been considered a physiologic inducer of cell differentiation for U937 cells (6, 43) . It was of interest, therefore, to investigate whether the addition of hydroxyvitD3 to HIV-infected U937 cells would result in any altered pattern of cell differentiation with respect to uninfected U937 cultures. Figure 2 shows the patterns of membrane antigens (i.e., OKM1, OKM5, LeuM3, HLA-DR, and CD4) of untreated and hydroxyvitD3-treated cell cultures for either HIV-infected or control U937 cells on day 6 of cell culture. HydroxyvitD3 treatment of HIV-infected U937 cells resulted in a clear-cut increase in the expression of OKM1, OKM5, and HLA-DR antigens as compared with hydroxyvitD3-treated control cells. In contrast, no relevant change in the expression of LeuM3 antigen was observed. Figure 3 shows the kinetics of CD4 expression in uninfected and HIV-infected U937 cells at different time intervals after cell seeding in the presence or absence of hydroxyvitD3.
Together, these results suggest that (i) HIV-infected U937 cells are more sensitive than their uninfected counterparts to hydroxyvitD3-induced monocyte differentiation and (ii) a drastic down-regulation of CD4 antigen expression occurs at any time for both undifferentiated and vitamin D3-treated HIV-infected cells.
Increased virus expression in hydroxyvitD3-treated HIVinfected U937 cells. It was of interest to investigate whether the vitamin D3-induced differentiation of chronically infected U937 cells might be associated with any alterations in HIV production.
Estimation of HIV production carried out by monitoring only one parameter has often led to misleading results. To assess HIV expression, we measured RT activity, p24 antigen, and biologically infectious virus in both culture supernatants and cell pellets of chronically infected U937 cells. Figure 4 shows the results of a representative experiment in which HIV production was monitored by the combination of these approaches in both control and hydroxyvitD3-treated cultures. HydroxyvitD3-treated U937 cells released higher amounts of HIV than control untreated cells did, as revealed by measuring p24 antigen (Fig. 4A ), RT activity (Fig. 4B) , and released (Fig. 4C) or cell-associated (Fig. 4D) infectious HIV. In particular, infectious virus markedly increased on day 6 after the addition of hydroxyvitD3 (Fig. 4C and D) ( Fig. 4D) , indicating that hydroxyvitD3 treatment had resulted in increased virus production and not only in increased release of preformed particles. In a set of 14 separate experiments, vitamin D3 was always capable of increasing the p24 levels in the culture medium with respect to control U937 cells (a mean increase of 3.2-fold was observed). The statistical analysis of the results by the paired Student t test indicated that vitamin D3 induced a significant increase in p24 levels in the culture media as compared with control cultures (P < 0.05). An increased release of HIV was also observed 1 to 3 days after hydroxyvitD3 treatment (data not shown). Likewise, hydroxyvitD3 induced an increase in HIV production in two cloned cell lines derived from HIVinfected U937 cells. In particular, vitamin D3 induced a more marked increase of HIV production (i.e., a ninefold increase in p24 levels) in low virus-producer cloned cells than in U937 cells (three-to fourfold increase) exhibiting a high virusproducer phenotype (data not shown).
Characterization of cytokine expression in uninfected and HIV-infected U937 cells and effects of hydroxyvitD3 treatment. Virus expression in chronically infected U937 cells could be positively or negatively influenced by the production of endogenous cytokines, which have been reported to up-regulate or inhibit HIV expression. It was of interest, therefore, to characterize the cytokine expression in control and HIV-infected U937 cells in the absence or presence of hydroxyvitD3.
High cells) and relatively low levels of TNF-o (1.5 to 3.0 pg/ml/106 cells) were found in U937 cell supernatants. However, no significant differences in the levels of these two cytokines were observed between the infected and uninfected cultures in the presence or absence of hydroxyvitD3 (data not shown). IL-la was not detected in any of these cell supernatants. Barely detectable levels of IFN (i.e., 1 to 2 U/ml) were only occasionally found in HIV-infected U937 cells.
It was of interest, therefore, to investigate the intracellular expression of some cytokines by means of very sensitive experimental approaches. We then analyzed the levels of specific mRNAs by the PCR technique.
Both uninfected and HIV-infected U937 cells expressed measurable levels of specific mRNAs for IFN-at and TNF-ot (Fig. 5) . Such levels were barely detectable on day 6 of cell culture in both control and vitamin D3-treated cultures (data not shown).
Measurable levels of mRNAs for IFN-P, IL-11, and IL-6 were also observed in both uninfected and HIV-infected U937 cells (data not shown).
Possible roles of cytokines in the regulation of HIV expression in chronically infected U937 cells. The addition of 1,000 U of either IFN-a or IFN-P per ml to HIV-infected U937 cells resulted in some inhibition of virus production (Fig. 6 ). This inhibitory effect was less marked for IFN-I than for IFN-ot (Fig. 6A) , even though both IFN-ao and IFN-P produced similar (i.e., 30-fold) increases in the levels of 2-5A synthetase with respect to control untreated cultures (data not shown). Both IFN-oa and IFN-1 exhibited strong inhibitory effects on HIV production in vitamin D3-treated U937 cells (Fig. 6B) ; these effects were more marked than those observed for control cultures. Some inhibitory effect on HIV production (i.e., 20 to 30%) was also observed in cultures treated with 50 to 100 U of IFN-ax or IFN-P per ml.
In contrast, TNF-ax induced an increase in virus release from both untreated (Fig. 6A) and vitamin D3-treated ( x 105/ml in the presence or absence of vitamin D3 as described in Materials and Methods. Cytokines were added on day 0 and on day 3. After 6 days of culture, the cells were counted and centrifuged, and the culture supernatants were tested for the p24 antigen as described in Materials and Methods. Cytokine treatments were as follows: IFN-a2, 1,000 U/ml; IFN-P, 1,000 U/ml; and TNF-a, 100 U/ml. The values represent the percentages of p24 variation in the cell-free media with respect to control untreated U937 cells. There were duplicate samples for each experimental condition. The variability of replicate samples was always less than 10%. Similar values were obtained with cell supernatants from 3-day-old cultures. 6B) U937 cells. TNF-a treatment resulted in a marked increase of the infectious HIV yield (Fig. 7) ; in fact, on day 6, there was a 10-fold increase in virus production in TNF-treated U937 cells compared with control untreated cells (Fig. 7A) . Very similar results were obtained by measuring cell-associated infectious HIV (Fig. 7B) , indicating that the TNF-a treatment had resulted in an increased level of virus production and not only in an increased release of preformed particles.
IL-lp (100 U/ml) did not significantly affect HIV production (data not shown).
To explore the possible roles of endogenous cytokines (i.e. , IFN-a, IFN- Effects of TNF on the production of infectious HIV. HIV-infected U937 cells were seeded in fresh medium in the presence or absence of TNF-a (100 U/ml). On day 3, the cell cultures were diluted 1:2 with fresh medium containing the same TNF concentration. On day 6, the cells were counted and centrifuged, and both the released and the cell-associated infectious viruses were titrated as described in Materials and Methods. different cytokines. The addition of antibodies to IFN-a2 resulted in a clear-cut increase of HIV production in both control and vitamin D3-treated cell cultures (Fig. 8) . In contrast, the addition of anti-IFN-, antibody caused a reduction of HIV production in untreated U937 cells, whereas it significantly increased virus production in vitamin D3-treated cultures. Treatment of both control and vitamin D3-treated U937 cells with antibodies to TNF-ot resulted in a marked decrease in HIV production (Fig. 8) .
Increased expression of TNF receptors in hydroxyvitD3-treated HIV-infected U937 cells. Although no differences were observed in the amounts of endogenous TNF production in control and vitamin D3-treated cell cultures, the increased HIV production in differentiated U937 cells might have been due to an increased sensitivity to the autocrine TNF production. It seemed of interest, therefore, to investigate the expression of TNF-a receptors in control and vitamin D3-treated U937 cells.
After hydroxyvitD3 induction, HIV-infected U937 cells exhibited a larger number of TNF-ao receptors than untreated HIV-infected cells did (Fig. 9) . Further 
DISCUSSION
In this article we have studied the possible correlations among virus production, cell differentiation, and cytokine production in chronically HIV-infected U937 cells. In particular, we emphasize and discuss the following aspects of our study.
Cell surface antigens of undifferentiated and vitamin D3-treated HIV-infected U937 cells. The expression of several membrane markers was evaluated by monoclonal antibodies OKM1, TecMG2, TecMG3, LeuMl, LeuM3, OKM14, OKM13, OKM5, anti-HLA-DR, anti-HLA-DQ, anti-HLA-DP, and OKT4 and was measured in both HIV-infected and control U937 cells. The HIV-infected U937 cells did not exhibit any significant change in those membrane antigens considered to be associated with cell differentiation (i.e., OKM1, OKM5, etc.) as compared with their uninfected counterparts. This cell system appears to differ, therefore, from that described by Petit and coworkers (35) , in which an increased expression of some differentiation markers (i.e., adhesion molecules and nonspecific esterase activity) was detected in HIV-infected cells. However, after 6 days of treatment with vitamin D3, HIV-infected U937 cells exhibited higher levels of OKM1 antigen than vitamin D3-treated uninfected cells exhibited (Fig. 2) , suggesting that the virusinfected cells exhibit a higher capacity for macrophagelike differentiation than their uninfected counterparts exhibit.
HIV-infected cells exhibited a marked reduction in the expression of CD4, HLA-DR, and HLA-DP antigens (Fig.   1B) . Such (28) , and U937 cells (28, 35) . Such variations have been interpreted in light of the proximity of the CD4 receptors to the HLA-DR antigens (2, 29) . The chronically infected U937 cells described in this article exhibited a strong reduction in the levels of HLA-DR and HLA-DP antigens compared with their uninfected counterparts (Fig. 1B) . In this context, other authors have reported increased HLA expression in freshly HIV-infected monocytes and U937 cells (28) . Together, these data suggest that the down-regulation of HLA antigens can occur in chronically HIV-infected cells, as recently pointed out by Kerkau and coworkers (24) , and that HLA antigens can be differently modulated depending on the time of HIV infection.
Correlation between HIV production and cell differentiation in chronically infected U937 cells. Folks and coworkers reported that the addition of PMA to a cloned line of chronically infected U937 cells resulted in a marked increase of HIV production (11) . However, no clear-cut correlations between the extent of virus production and cell differentiation upon long-term treatment with physiologic stimuli such as vitamin D3 have been found so far. The results reported in this article clearly indicate that treatment of HIV-infected U937 cells with vitamin D3 results in a marked increase in virus production (Fig. 4) which parallels the induction of differentiation markers (i.e., OKM1 and LeuM3). A direct correlation between OKM1 expression and HIV production was also found on days 1 and 3 of vitamin D3 treatment of HIV-infected cells (data not shown), further indicating a strong association between cell differentiation and virus production in this system. These results seem to be in agreement with the fact that monocyte-derived macrophages are capable of producing higher amounts of HIV than freshly isolated monocytes (16) .
Effects of endogenous and exogenous cytokines in the regulation of HIV production. HIV-infected U937 cells are capable of expressing a number of cytokines (IFN-ox, IFN-P, TNF-a, IL-1p, and IL-6), as determined either by measuring the released proteins in the culture supernatants or by PCR detection of specific mRNAs (Fig. 5) . Alterations in cytokine production in different HIV-infected cell systems compared with uninfected control cells have been described. Although no major changes in the detectable levels of the released cytokines have been observed in HIV-infected U937 cells (data not shown), a greater accumulation of TNF-ao mRNA was found in virus-infected cells than in control cells (Fig. 5) . Some of the cytokines found to be expressed in HIVinfected cells exerted clear-cut effects on HIV production. Both IFN-o and IFN-r exerted some inhibitory effect on HIV production, even though the effect was more marked in vitamin D3-treated U937 cells (Fig. 6) ; such results are in keeping with data provided by some authors with different HIV-infected cell systems (reviewed in reference 25). In contrast, the addition of TNF markedly increased HIV production ( Fig. 6 and 7) . Some reports have shown similar enhancing effects of TNF on HIV production (9, 22, 32) , even though inhibitory effects have also been described (44) . In particular, Griffin and coworkers (18) have recently reported that TNF can increase HIV production in a cloned line of chronically infected U937 cells; this HIV production was supposed to be mediated by increased NF-KB-binding activity.
HIV production was significantly increased by the addition of monoclonal antibodies to IFN-ao2 (Fig. 8) , as well as polyclonal anti-IFN-ot antibody (data not shown), in both untreated and vitamin D3-treated cell cultures. These data appear to be in agreement with those reported by Mace and coworkers (27) and indicate the existence of a role for endogenous IFN-a in the restriction of virus expression. The addition of antibodies to IFN-1 resulted in increased HIV production only in vitamin D3-treated cultures, whereas some inhibitory effects were observed in control undifferentiated U937 cells (data not shown). These data are rather intriguing and suggest that endogenous IFN-, can exert some complex effect on HIV production in this system, possibly related in some way to the effects on the cell cycle, cell differentiation, or both. In this context, it is of interest to mention that endogenous IFN has been considered to play some role(s) in the inhibition of cell proliferation (43) and in the differentiation process (46) in U937 cells. HIV production was markedly inhibited by the addition of antibodies to TNF-a in both control and vitamin D3-treated cultures (Fig. 8) , indicating that autocrine TNF may exert some role in promoting HIV production in this system. The finding that vitamin D3 treatment of HIV-infected U937 cells results in an increased expression of TNF receptors (Fig. 9) , as well as in an enhanced sensitivity to TNF (data not shown), suggests the possibility that even very low levels of endogenous TNF-a may play an important role in increased HIV production in differentiating U937 cells. However, it is worth emphasizing that endogenous TNF is not likely to represent the unique factor involved in the increased HIV production induced by vitamin D3 treatment. In fact, antibodies to TNF only partially inhibited the enhancing effects of vitamin D3 on HIV production.
In conclusion, the results reported in this article demonstrate a strong correlation between HIV production and vitamin D3-induced macrophagelike differentiation in chronically infected U937 cells and indicate that endogenous IFN and TNF exert opposite effects on the regulation of virus production in both undifferentiated and vitamin D3-treated cell cultures.
